Efficacy and Safety Study of Tafenoquine (TQ) Co-administered With Dihydroartemisinin-piperaquine (DHA-PQP) for the Radical Cure of Plasmodium Vivax (P. Vivax) Malaria

NCT02802501 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Malaria, Vivax

Interventions

DRUG: Tafenoquine
DRUG: Matched-Placebo for Tafenoquine
DRUG: Primaquine
DRUG: Matched-Placebo for Primaquine
DRUG: Dihydroartemisinin-piperaquine (DHA-PQP)
DRUG: ACT plus PQ (Rescue medication)
DRUG: PQ (End of study treatment)

Sponsor

GlaxoSmithKline

Collaborators

[object Object]